Repligen Corporation (RGEN) compared with its closest peers (TECH, HAE, RVTY, TWST, HBIO): P/E 241.2 vs industry 16.0. Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Bio-Techne, Haemonetics, Revvity, Twist Bioscience, Harvard Bioscience, Agilent Technologies, Alpha Teknova and KORU Medical Systems share Repligen's sub-industry, biological products makers.
| Company | Market Cap | P/E |
|---|---|---|
| Bio-Techne Corp (TECH) | $11.34B | 89.1 |
| Haemonetics Corporation (HAE) | $4.96B | 51.5 |
| Revvity, Inc. (RVTY) | $16.01B | 67.4 |
| Twist Bioscience Corporation (TWST) | $10.40B | — |
| Harvard Bioscience, Inc. (HBIO) | $33.71M | — |
| Agilent Technologies, Inc. (A) | $44.11B | 30.6 |
| Alpha Teknova, Inc. (TKNO) | $418.73M | — |
| KORU Medical Systems, Inc. (KRMD) | $160.16M | — |
| Neogen Corporation (NEOG) | $2.83B | — |
| Organogenesis Holdings Inc. (ORGO) | $181.43M | 18.2 |
| Stock P/E | 241.2 |
| Sector P/E (Healthcare) | 21.5 |
| Industry P/E (Pharmaceutical Products) | 16.0 |
| vs Sector | 1023.4% |
| vs Industry | 1405.7% |
RGEN overview · RGEN earnings · RGEN financials · RGEN KPIs · RGEN documents · RGEN ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.